Vertos is a medical device company that has developed and commercialized the mild® procedure, an innovative, minimally invasive treatment for lumbar spinal stenosis (LSS).
LSS is primarily a degenerative, age-related narrowing of the lower spinal canal that is diagnosed in more than two million individuals in the U.S. each year. LSS symptoms include pain and numbness in the lower back, legs, or buttocks, which limits the patient's ability to stand and walk.
mild® offers a safe, outpatient, minimally invasive, fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. mild® has been performed on over 25,000 patients and has been proven to be safe and effective in 14 clinical studies and more than 20 peer-reviewed journal articles. Clinical trials demonstrate that mild® can help LSS patients stand longer and walk farther with less pain, and no major device-related complications have been reported.
Vertos is based in Aliso Viejo, CA. Hugo Harrod and Eric Fritz represent MVM’s investment in the company, and Hugo has joined the Board of Directors.
Mr. Eric Wichems
President and Chief Executive Officer
95 Enterprise, Suite 325